16 employees
Breath Therapeutics is a private clinical-stage biopharmaceutical company.
2016
$46M
from 3 investors over 3 rounds
Breath Therapeutics-a Zambon Group Company raised $46M on March 8, 2017
Investors: Gimv, Gilde Healthcare and Sofinnova Partners